WASHINGTON -- The U.S. Food and Drug Administration rejected a request to ban a contested chemical from cans and other packaging because opponents didn't provide enough data to support a rule change.

Continued study of bisphenol A, known as BPA, including completion of federal studies currently in progress, is the most appropriate course of action, the agency said in an e-mail Friday. The chemical has been used in epoxy linings since the 1960s to extend the shelf life of canned foods and beverages.

Manufacturers of baby bottles and cups have stopped using polycarbonate containing BPA in response to consumer concerns it may affect children. Campbell Soup Co. is among food makers phasing out the use of BPA, while beverage companies such as Coca-Cola Co. have kept the chemical, saying it's safe.

"The information provided in your petition was not sufficient to persuade FDA, at this time, to initiate rulemaking to prohibit the use of BPA in human food and food packaging," David H. Horsey, an acting associate FDA commissioner, said today in a letter to the Natural Resources Defense Council.

Advertise with us

NRDC, a New York-based environmental advocacy group, petitioned the FDA in 2008 to ban its use in food and drinks packaging. BPA, produced by combining phenol and acetone, mimics the female hormone estrogen and may affect the brain and prostate gland in fetuses and young children, according to the National Institutes of Health.

A ban would hurt profits at can-maker Silgan Holdings Inc. and others in the $60 billion industry, Ghansham Panjabi, an analyst at Robert W. Baird & Co., said. The biggest U.S. producer of BPA is Saudi Basic Industries Corp., followed by Bayer AG and Dow Chemical Co.

The FDA plans to complete an updated safety review of BPA this year and will make any changes to the chemical's status based on the science, an agency spokesman, said in an e-mail.

Federally funded research confirms that the human body quickly processes and eliminates BPA, making it "very unlikely" that the chemical causes harm, the American Chemistry Council, a Washington-based industry group, said in a statement today.

Sarah Janssen, a senior scientist at the NRDC, said the FDA's denial of a ban shows "a major overhaul" of chemical regulation is needed.